Pharma & Healthcare
Global Artificial Blood Substitute Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 344234
- Pages: 123
- Figures: 121
- Views: 3
In 2024, the global market size of Artificial Blood Substitute was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of 22.4% during the forecast period 2025-2031.
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people"s demand for blood and make up for the current blood shortage.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Blood Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Substitute.
The Artificial Blood Substitute market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Blood Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Substitute companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Segment by Application
Military
Civil
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Artificial Blood Substitute in global and regional level.
Chapter 3: Detailed analysis of Artificial Blood Substitute company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Substitute revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people"s demand for blood and make up for the current blood shortage.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Blood Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Substitute.
The Artificial Blood Substitute market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Blood Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Substitute companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Segment by Application
Military
Civil
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Artificial Blood Substitute in global and regional level.
Chapter 3: Detailed analysis of Artificial Blood Substitute company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Substitute revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Artificial Blood Substitute Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Market by Application
1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Military
1.3.3 Civil
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Blood Substitute Market Size Estimates and Forecasts
2.2 Artificial Blood Substitute Market Size by Region: 2024 Versus 2031
2.2.1 Global Artificial Blood Substitute Revenue by Region: 2020-2025
2.2.2 Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031)
2.2.3 Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Artificial Blood Substitute Revenue by Type (2020-2031)
3.1.2 Global Artificial Blood Substitute Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Artificial Blood Substitute Revenue by Application (2020-2031)
3.2.2 Global Artificial Blood Substitute Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application
3.3.2 Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application
4 Global Artificial Blood Substitute by Company
4.1 Global Artificial Blood Substitute Revenue by Company (2020-2025)
4.2 Global Artificial Blood Substitute Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Artificial Blood Substitute Companies around the World: Ranking by Revenue
4.3.2 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Artificial Blood Substitute Companies Headquarters & Product Type
4.4.1 Global Artificial Blood Substitute Companies Headquarters
4.4.2 Date of International Companies Enter into Artificial Blood Substitute Market
4.4.3 Global Artificial Blood Substitute Companies Product & Service
4.4.4 Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.4.5 Hemoglobin-based Oxygen Carrier (HBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.5 Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Aurum Biosciences Ltd.
5.1.1 Aurum Biosciences Ltd. Corporation Information
5.1.2 Aurum Biosciences Ltd. Description, Business Overview
5.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
5.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.1.5 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.1.6 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.1.7 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.1.8 Aurum Biosciences Ltd. Recent Developments
5.2 HEMARINA SA
5.2.1 HEMARINA SA Corporation Information
5.2.2 HEMARINA SA Description, Business Overview
5.2.3 HEMARINA SA Artificial Blood Substitute Products Offered
5.2.4 HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.2.5 HEMARINA SA Artificial Blood Substitute Revenue by Product in 2024
5.2.6 HEMARINA SA Artificial Blood Substitute Revenue by Application in 2024
5.2.7 HEMARINA SA Artificial Blood Substitute Revenue by Geographic Area in 2024
5.2.8 HEMARINA SA Recent Developments
5.3 HbO2 Therapeutics
5.3.1 HbO2 Therapeutics Corporation Information
5.3.2 HbO2 Therapeutics Description, Business Overview
5.3.3 HbO2 Therapeutics Artificial Blood Substitute Products Offered
5.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.3.5 HbO2 Therapeutics Artificial Blood Substitute Revenue by Product in 2024
5.3.6 HbO2 Therapeutics Artificial Blood Substitute Revenue by Application in 2024
5.3.7 HbO2 Therapeutics Artificial Blood Substitute Revenue by Geographic Area in 2024
5.3.8 HbO2 Therapeutics Recent Developments
5.4 KaloCyte Inc.
5.4.1 KaloCyte Inc. Corporation Information
5.4.2 KaloCyte Inc. Description, Business Overview
5.4.3 KaloCyte Inc. Artificial Blood Substitute Products Offered
5.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.4.5 KaloCyte Inc. Artificial Blood Substitute Revenue by Product in 2024
5.4.6 KaloCyte Inc. Artificial Blood Substitute Revenue by Application in 2024
5.4.7 KaloCyte Inc. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.4.8 KaloCyte Inc. Recent Developments
5.5 SpheriTech Ltd.
5.5.1 SpheriTech Ltd. Corporation Information
5.5.2 SpheriTech Ltd. Description, Business Overview
5.5.3 SpheriTech Ltd. Artificial Blood Substitute Products Offered
5.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.5.5 SpheriTech Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.5.6 SpheriTech Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.5.7 SpheriTech Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.5.8 SpheriTech Ltd. Recent Developments
5.6 NuvOx Pharma
5.6.1 NuvOx Pharma Corporation Information
5.6.2 NuvOx Pharma Description, Business Overview
5.6.3 NuvOx Pharma Artificial Blood Substitute Products Offered
5.6.4 NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.6.5 NuvOx Pharma Artificial Blood Substitute Revenue by Product in 2024
5.6.6 NuvOx Pharma Artificial Blood Substitute Revenue by Application in 2024
5.6.7 NuvOx Pharma Artificial Blood Substitute Revenue by Geographic Area in 2024
5.6.8 NuvOx Pharma Recent Developments
6 North America
6.1 North America Artificial Blood Substitute Market Size YoY Growth 2020-2031
6.2 North America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
6.3 North America Artificial Blood Substitute Revenue by Type (2020-2025)
6.4 North America Artificial Blood Substitute Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Artificial Blood Substitute Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Artificial Blood Substitute Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025)
7.4 Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025)
8 Europe
8.1 Europe Artificial Blood Substitute Market Size YoY Growth 2020-2031
8.2 Europe Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
8.3 Europe Artificial Blood Substitute Revenue by Type (2020-2025)
8.4 Europe Artificial Blood Substitute Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
9.2 Latin America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
9.3 Latin America Artificial Blood Substitute Revenue by Type (2020-2025)
9.4 Latin America Artificial Blood Substitute Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025)
10.4 Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Artificial Blood Substitute Supply Chain Analysis
11.2 Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
11.3 Artificial Blood Substitute Clients Analysis
11.4 Artificial Blood Substitute Sales Channel and Sales Model Analysis
11.4.1 Artificial Blood Substitute Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Artificial Blood Substitute Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Artificial Blood Substitute Distributors
12 Artificial Blood Substitute Market Dynamics
12.1 Artificial Blood Substitute Industry Trends
12.2 Artificial Blood Substitute Market Drivers
12.3 Artificial Blood Substitute Market Challenges
12.4 Artificial Blood Substitute Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Artificial Blood Substitute Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Market by Application
1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Military
1.3.3 Civil
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Blood Substitute Market Size Estimates and Forecasts
2.2 Artificial Blood Substitute Market Size by Region: 2024 Versus 2031
2.2.1 Global Artificial Blood Substitute Revenue by Region: 2020-2025
2.2.2 Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031)
2.2.3 Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Artificial Blood Substitute Revenue by Type (2020-2031)
3.1.2 Global Artificial Blood Substitute Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Artificial Blood Substitute Revenue by Application (2020-2031)
3.2.2 Global Artificial Blood Substitute Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application
3.3.2 Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application
4 Global Artificial Blood Substitute by Company
4.1 Global Artificial Blood Substitute Revenue by Company (2020-2025)
4.2 Global Artificial Blood Substitute Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Artificial Blood Substitute Companies around the World: Ranking by Revenue
4.3.2 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Artificial Blood Substitute Companies Headquarters & Product Type
4.4.1 Global Artificial Blood Substitute Companies Headquarters
4.4.2 Date of International Companies Enter into Artificial Blood Substitute Market
4.4.3 Global Artificial Blood Substitute Companies Product & Service
4.4.4 Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.4.5 Hemoglobin-based Oxygen Carrier (HBOC) Revenue Market Share of Artificial Blood Substitute by Company
4.5 Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Aurum Biosciences Ltd.
5.1.1 Aurum Biosciences Ltd. Corporation Information
5.1.2 Aurum Biosciences Ltd. Description, Business Overview
5.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
5.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.1.5 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.1.6 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.1.7 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.1.8 Aurum Biosciences Ltd. Recent Developments
5.2 HEMARINA SA
5.2.1 HEMARINA SA Corporation Information
5.2.2 HEMARINA SA Description, Business Overview
5.2.3 HEMARINA SA Artificial Blood Substitute Products Offered
5.2.4 HEMARINA SA Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.2.5 HEMARINA SA Artificial Blood Substitute Revenue by Product in 2024
5.2.6 HEMARINA SA Artificial Blood Substitute Revenue by Application in 2024
5.2.7 HEMARINA SA Artificial Blood Substitute Revenue by Geographic Area in 2024
5.2.8 HEMARINA SA Recent Developments
5.3 HbO2 Therapeutics
5.3.1 HbO2 Therapeutics Corporation Information
5.3.2 HbO2 Therapeutics Description, Business Overview
5.3.3 HbO2 Therapeutics Artificial Blood Substitute Products Offered
5.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.3.5 HbO2 Therapeutics Artificial Blood Substitute Revenue by Product in 2024
5.3.6 HbO2 Therapeutics Artificial Blood Substitute Revenue by Application in 2024
5.3.7 HbO2 Therapeutics Artificial Blood Substitute Revenue by Geographic Area in 2024
5.3.8 HbO2 Therapeutics Recent Developments
5.4 KaloCyte Inc.
5.4.1 KaloCyte Inc. Corporation Information
5.4.2 KaloCyte Inc. Description, Business Overview
5.4.3 KaloCyte Inc. Artificial Blood Substitute Products Offered
5.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.4.5 KaloCyte Inc. Artificial Blood Substitute Revenue by Product in 2024
5.4.6 KaloCyte Inc. Artificial Blood Substitute Revenue by Application in 2024
5.4.7 KaloCyte Inc. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.4.8 KaloCyte Inc. Recent Developments
5.5 SpheriTech Ltd.
5.5.1 SpheriTech Ltd. Corporation Information
5.5.2 SpheriTech Ltd. Description, Business Overview
5.5.3 SpheriTech Ltd. Artificial Blood Substitute Products Offered
5.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.5.5 SpheriTech Ltd. Artificial Blood Substitute Revenue by Product in 2024
5.5.6 SpheriTech Ltd. Artificial Blood Substitute Revenue by Application in 2024
5.5.7 SpheriTech Ltd. Artificial Blood Substitute Revenue by Geographic Area in 2024
5.5.8 SpheriTech Ltd. Recent Developments
5.6 NuvOx Pharma
5.6.1 NuvOx Pharma Corporation Information
5.6.2 NuvOx Pharma Description, Business Overview
5.6.3 NuvOx Pharma Artificial Blood Substitute Products Offered
5.6.4 NuvOx Pharma Artificial Blood Substitute Revenue and Gross Margin (2020-2025)
5.6.5 NuvOx Pharma Artificial Blood Substitute Revenue by Product in 2024
5.6.6 NuvOx Pharma Artificial Blood Substitute Revenue by Application in 2024
5.6.7 NuvOx Pharma Artificial Blood Substitute Revenue by Geographic Area in 2024
5.6.8 NuvOx Pharma Recent Developments
6 North America
6.1 North America Artificial Blood Substitute Market Size YoY Growth 2020-2031
6.2 North America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
6.3 North America Artificial Blood Substitute Revenue by Type (2020-2025)
6.4 North America Artificial Blood Substitute Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Artificial Blood Substitute Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Artificial Blood Substitute Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025)
7.4 Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025)
8 Europe
8.1 Europe Artificial Blood Substitute Market Size YoY Growth 2020-2031
8.2 Europe Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
8.3 Europe Artificial Blood Substitute Revenue by Type (2020-2025)
8.4 Europe Artificial Blood Substitute Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
9.2 Latin America Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
9.3 Latin America Artificial Blood Substitute Revenue by Type (2020-2025)
9.4 Latin America Artificial Blood Substitute Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Artificial Blood Substitute Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025)
10.4 Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Artificial Blood Substitute Supply Chain Analysis
11.2 Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
11.3 Artificial Blood Substitute Clients Analysis
11.4 Artificial Blood Substitute Sales Channel and Sales Model Analysis
11.4.1 Artificial Blood Substitute Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Artificial Blood Substitute Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Artificial Blood Substitute Distributors
12 Artificial Blood Substitute Market Dynamics
12.1 Artificial Blood Substitute Industry Trends
12.2 Artificial Blood Substitute Market Drivers
12.3 Artificial Blood Substitute Market Challenges
12.4 Artificial Blood Substitute Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Artificial Blood Substitute Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Artificial Blood Substitute Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Artificial Blood Substitute Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Artificial Blood Substitute Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Artificial Blood Substitute Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Artificial Blood Substitute Revenue by Company (2020-2025) & (US$ Million)
Table 11. Artificial Blood Substitute Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Artificial Blood Substitute Players by Revenue (US$ Million) in 2024
Table 13. Global Artificial Blood Substitute Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Substitute as of 2024)
Table 15. Global Artificial Blood Substitute Companies Headquarters
Table 16. Date of International Companies Enter into Artificial Blood Substitute Market
Table 17. Global Artificial Blood Substitute Companies Product & Service
Table 18. Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
Table 19. Aurum Biosciences Ltd. Corporation Information
Table 20. Aurum Biosciences Ltd. Description and Business Overview
Table 21. Aurum Biosciences Ltd. Artificial Blood Substitute Product
Table 22. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 24. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 25. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 26. Aurum Biosciences Ltd. Recent Developments
Table 27. HEMARINA SA Corporation Information
Table 28. HEMARINA SA Description and Business Overview
Table 29. HEMARINA SA Artificial Blood Substitute Product
Table 30. HEMARINA SA Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 32. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 33. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 34. HEMARINA SA Recent Developments
Table 35. HbO2 Therapeutics Corporation Information
Table 36. HbO2 Therapeutics Description and Business Overview
Table 37. HbO2 Therapeutics Artificial Blood Substitute Product
Table 38. HbO2 Therapeutics Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 40. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 41. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 42. HbO2 Therapeutics Recent Developments
Table 43. KaloCyte Inc. Corporation Information
Table 44. KaloCyte Inc. Description and Business Overview
Table 45. KaloCyte Inc. Artificial Blood Substitute Product
Table 46. KaloCyte Inc. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 48. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 49. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 50. KaloCyte Inc. Recent Developments
Table 51. SpheriTech Ltd. Corporation Information
Table 52. SpheriTech Ltd. Description and Business Overview
Table 53. SpheriTech Ltd. Artificial Blood Substitute Product
Table 54. SpheriTech Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 56. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 57. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 58. SpheriTech Ltd. Recent Developments
Table 59. NuvOx Pharma Corporation Information
Table 60. NuvOx Pharma Description and Business Overview
Table 61. NuvOx Pharma Artificial Blood Substitute Product
Table 62. NuvOx Pharma Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 64. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 65. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 66. NuvOx Pharma Recent Developments
Table 67. North America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 68. North America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 69. North America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 70. North America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 71. Asia-Pacific Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
Table 72. Asia-Pacific Artificial Blood Substitute Revenue by Region (2026-2031) & (US$ Million)
Table 73. Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 74. Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 75. Europe Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 76. Europe Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 77. Europe Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 78. Europe Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 79. Latin America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 80. Latin America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 81. Latin America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 82. Latin America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 83. Middle East and Africa Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 84. Middle East and Africa Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 85. Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 86. Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 87. Artificial Blood Substitute Key Raw Materials, Industry Status and Trend
Table 88. Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
Table 89. Artificial Blood Substitute Clients Status and Trend
Table 90. Artificial Blood Substitute Typical Clients
Table 91. Artificial Blood Substitute Distributors
Table 92. Artificial Blood Substitute Market Trends
Table 93. Artificial Blood Substitute Market Drivers
Table 94. Artificial Blood Substitute Market Challenges
Table 95. Artificial Blood Substitute Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Blood Substitute Product Picture
Figure 2. Global Artificial Blood Substitute Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Artificial Blood Substitute Revenue Market Share by Type in 2024 & 2031
Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Product Picture
Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Product Picture
Figure 6. Global Artificial Blood Substitute Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Artificial Blood Substitute Revenue Market Share by Application in 2024 & 2031
Figure 8. Military
Figure 9. Civil
Figure 10. Artificial Blood Substitute Report Years Considered
Figure 11. Global Artificial Blood Substitute Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Artificial Blood Substitute Market Size (2020-2031) & (US$ Million)
Figure 13. Global Artificial Blood Substitute Market Size Market Share by Region: 2024 Versus 2031
Figure 14. Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
Figure 15. Global Artificial Blood Substitute Revenue Market Share Forecast by Type (2020-2031)
Figure 16. Global Artificial Blood Substitute Revenue Market Share Forecast by Application (2020-2031)
Figure 17. Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
Figure 18. Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
Figure 19. Artificial Blood Substitute Revenue Share by Company (2024)
Figure 20. Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Proportion by Company in 2024
Figure 22. Hemoglobin-based Oxygen Carrier (HBOC) Revenue Proportion by Company in 2024
Figure 23. North America Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
Figure 24. North America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 25. North America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
Figure 27. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
Figure 28. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 29. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 30. Europe Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 31. Europe Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 32. Europe Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 33. Europe Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 34. Latin America Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Latin America Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 36. Latin America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 37. Latin America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 38. Middle East and Africa Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 40. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 41. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 42. Artificial Blood Substitute Supply Chain (Upstream and Downstream Market)
Figure 43. Global Production Market Share of Artificial Blood Substitute Raw Materials by Region in 2024
Figure 44. Artificial Blood Substitute Distribution Channels
Figure 45. Global Artificial Blood Substitute Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 46. Global Artificial Blood Substitute Percentage 2020-2031: Online Sales VS Offline Sales
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Table 1. Global Artificial Blood Substitute Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Artificial Blood Substitute Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Artificial Blood Substitute Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Artificial Blood Substitute Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Artificial Blood Substitute Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Artificial Blood Substitute Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Artificial Blood Substitute Revenue by Company (2020-2025) & (US$ Million)
Table 11. Artificial Blood Substitute Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Artificial Blood Substitute Players by Revenue (US$ Million) in 2024
Table 13. Global Artificial Blood Substitute Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Artificial Blood Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Substitute as of 2024)
Table 15. Global Artificial Blood Substitute Companies Headquarters
Table 16. Date of International Companies Enter into Artificial Blood Substitute Market
Table 17. Global Artificial Blood Substitute Companies Product & Service
Table 18. Global Artificial Blood Substitute Mergers & Acquisitions, Expansion Plans
Table 19. Aurum Biosciences Ltd. Corporation Information
Table 20. Aurum Biosciences Ltd. Description and Business Overview
Table 21. Aurum Biosciences Ltd. Artificial Blood Substitute Product
Table 22. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 24. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 25. Aurum Biosciences Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 26. Aurum Biosciences Ltd. Recent Developments
Table 27. HEMARINA SA Corporation Information
Table 28. HEMARINA SA Description and Business Overview
Table 29. HEMARINA SA Artificial Blood Substitute Product
Table 30. HEMARINA SA Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 32. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 33. HEMARINA SA Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 34. HEMARINA SA Recent Developments
Table 35. HbO2 Therapeutics Corporation Information
Table 36. HbO2 Therapeutics Description and Business Overview
Table 37. HbO2 Therapeutics Artificial Blood Substitute Product
Table 38. HbO2 Therapeutics Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 40. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 41. HbO2 Therapeutics Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 42. HbO2 Therapeutics Recent Developments
Table 43. KaloCyte Inc. Corporation Information
Table 44. KaloCyte Inc. Description and Business Overview
Table 45. KaloCyte Inc. Artificial Blood Substitute Product
Table 46. KaloCyte Inc. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 48. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 49. KaloCyte Inc. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 50. KaloCyte Inc. Recent Developments
Table 51. SpheriTech Ltd. Corporation Information
Table 52. SpheriTech Ltd. Description and Business Overview
Table 53. SpheriTech Ltd. Artificial Blood Substitute Product
Table 54. SpheriTech Ltd. Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 56. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 57. SpheriTech Ltd. Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 58. SpheriTech Ltd. Recent Developments
Table 59. NuvOx Pharma Corporation Information
Table 60. NuvOx Pharma Description and Business Overview
Table 61. NuvOx Pharma Artificial Blood Substitute Product
Table 62. NuvOx Pharma Artificial Blood Substitute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Product in 2024
Table 64. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Application in 2024
Table 65. NuvOx Pharma Revenue Proportion of Artificial Blood Substitute by Geographic Area in 2024
Table 66. NuvOx Pharma Recent Developments
Table 67. North America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 68. North America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 69. North America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 70. North America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 71. Asia-Pacific Artificial Blood Substitute Revenue by Region (2020-2025) & (US$ Million)
Table 72. Asia-Pacific Artificial Blood Substitute Revenue by Region (2026-2031) & (US$ Million)
Table 73. Asia-Pacific Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 74. Asia-Pacific Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 75. Europe Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 76. Europe Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 77. Europe Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 78. Europe Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 79. Latin America Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 80. Latin America Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 81. Latin America Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 82. Latin America Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 83. Middle East and Africa Artificial Blood Substitute Revenue by Country (2020-2025) & (US$ Million)
Table 84. Middle East and Africa Artificial Blood Substitute Revenue by Country (2026-2031) & (US$ Million)
Table 85. Middle East and Africa Artificial Blood Substitute Revenue by Type (2020-2025) & (US$ Million)
Table 86. Middle East and Africa Artificial Blood Substitute Revenue by Application (2020-2025) & (US$ Million)
Table 87. Artificial Blood Substitute Key Raw Materials, Industry Status and Trend
Table 88. Artificial Blood Substitute Key Raw Materials and Upstream Suppliers
Table 89. Artificial Blood Substitute Clients Status and Trend
Table 90. Artificial Blood Substitute Typical Clients
Table 91. Artificial Blood Substitute Distributors
Table 92. Artificial Blood Substitute Market Trends
Table 93. Artificial Blood Substitute Market Drivers
Table 94. Artificial Blood Substitute Market Challenges
Table 95. Artificial Blood Substitute Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Blood Substitute Product Picture
Figure 2. Global Artificial Blood Substitute Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Artificial Blood Substitute Revenue Market Share by Type in 2024 & 2031
Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Product Picture
Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Product Picture
Figure 6. Global Artificial Blood Substitute Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Artificial Blood Substitute Revenue Market Share by Application in 2024 & 2031
Figure 8. Military
Figure 9. Civil
Figure 10. Artificial Blood Substitute Report Years Considered
Figure 11. Global Artificial Blood Substitute Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Artificial Blood Substitute Market Size (2020-2031) & (US$ Million)
Figure 13. Global Artificial Blood Substitute Market Size Market Share by Region: 2024 Versus 2031
Figure 14. Global Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
Figure 15. Global Artificial Blood Substitute Revenue Market Share Forecast by Type (2020-2031)
Figure 16. Global Artificial Blood Substitute Revenue Market Share Forecast by Application (2020-2031)
Figure 17. Perfluorocarbon-based Oxygen Carrier (PFBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
Figure 18. Hemoglobin-based Oxygen Carrier (HBOC) of Artificial Blood Substitute Revenue Market Share by Application, 2024 VS 2031
Figure 19. Artificial Blood Substitute Revenue Share by Company (2024)
Figure 20. Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Perfluorocarbon-based Oxygen Carrier (PFBOC) Revenue Proportion by Company in 2024
Figure 22. Hemoglobin-based Oxygen Carrier (HBOC) Revenue Proportion by Company in 2024
Figure 23. North America Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
Figure 24. North America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 25. North America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Artificial Blood Substitute Revenue 2020-2031 (US$ Million)
Figure 27. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Region (2020-2031)
Figure 28. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 29. Asia-Pacific Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 30. Europe Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 31. Europe Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 32. Europe Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 33. Europe Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 34. Latin America Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Latin America Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 36. Latin America Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 37. Latin America Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 38. Middle East and Africa Artificial Blood Substitute Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Country (2020-2031)
Figure 40. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Type (2020-2025)
Figure 41. Middle East and Africa Artificial Blood Substitute Revenue Market Share by Application (2020-2025)
Figure 42. Artificial Blood Substitute Supply Chain (Upstream and Downstream Market)
Figure 43. Global Production Market Share of Artificial Blood Substitute Raw Materials by Region in 2024
Figure 44. Artificial Blood Substitute Distribution Channels
Figure 45. Global Artificial Blood Substitute Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 46. Global Artificial Blood Substitute Percentage 2020-2031: Online Sales VS Offline Sales
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232